His primary scientific interests are in Epilepsy, Pediatrics, Status epilepticus, Internal medicine and Pharmacology. His research on Epilepsy concerns the broader Neuroscience. Eric D. Marsh has researched Pediatrics in several fields, including Adverse effect, Randomized controlled trial and Dravet syndrome.
His studies in Dravet syndrome integrate themes in fields like Young adult, Mortality rate, Clinical endpoint, Traditional medicine and Convulsion. The Oxidative stress research he does as part of his general Internal medicine study is frequently linked to other disciplines of science, such as Oligodendrocyte differentiation, therefore creating a link between diverse domains of science. His Pharmacology research is multidisciplinary, incorporating elements of Missense mutation, NMDA receptor, Memantine, Prospective cohort study and Epileptic spasms.
His scientific interests lie mostly in Epilepsy, Neuroscience, Electroencephalography, Pediatrics and Epilepsy surgery. His Epilepsy study focuses on Status epilepticus in particular. His Neuroscience research includes elements of GABAergic and Disease.
His study in Electroencephalography is interdisciplinary in nature, drawing from both Cognition and Audiology. His research in Pediatrics intersects with topics in Seizure types, Dravet syndrome, Natural history study, Epilepsy syndromes and Genetic testing. His Epilepsy surgery research also works with subjects such as
Eric D. Marsh focuses on Rett syndrome, Neurodevelopmental disorder, Neuroscience, Epilepsy and Disease. His Rett syndrome research also works with subjects such as
His study in the field of Ictal is also linked to topics like Chemistry. His Ictal research focuses on Epilepsy surgery and how it connects with Internal medicine. His Disease research includes themes of Phenotype, Hypoxia, Human genetics and Bioinformatics.
Eric D. Marsh mainly investigates Epilepsy, CDKL5, Rett syndrome, MECP2 and FOXG1. His Epilepsy research is multidisciplinary, relying on both Temporal cortex, Amyloid precursor protein and Amyloid. His CDKL5 research incorporates themes from Bioinformatics, Mutant, Intellectual disability, Neurodevelopmental disorder and Cortical visual impairment.
The study incorporates disciplines such as Seizure types, Natural history study, MECP2 duplication syndrome, Developmental regression and Pediatrics in addition to Rett syndrome. His work focuses on many connections between MECP2 and other disciplines, such as Clinical trial, that overlap with his field of interest in Neuroscience. His biological study deals with issues like Internal medicine, which deal with fields such as Electroencephalography.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
Orrin Devinsky;J. Helen Cross;Linda Laux;Eric Marsh.
The New England Journal of Medicine (2017)
Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
Orrin Devinsky;Eric Marsh;Daniel Friedman;Elizabeth Thiele.
Lancet Neurology (2016)
Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial
Elizabeth A Thiele;Eric D Marsh;Jacqueline A French;Maria Mazurkiewicz-Beldzinska.
The Lancet (2018)
Human and automated detection of high-frequency oscillations in clinical intracranial EEG recordings.
Andrew B. Gardner;Greg A. Worrell;Eric Marsh;Dennis Dlugos.
Clinical Neurophysiology (2007)
GRIN2A mutation and early‐onset epileptic encephalopathy: personalized therapy with memantine
Tyler Mark Pierson;Hongjie Yuan;Eric D. Marsh;Karin Fuentes-Fajardo.
Annals of clinical and translational neurology (2014)
Targeted Loss of Arx Results in a Developmental Epilepsy Mouse Model and Recapitulates the Human Phenotype in Heterozygous Females
Eric Marsh;Carl Fulp;Ernest Gomez;Ilya Nasrallah.
Loss of CDKL5 disrupts kinome profile and event-related potentials leading to autistic-like phenotypes in mice.
I-Ting Judy Wang;Megan Allen;Darren Goffin;Xinjian Zhu.
Proceedings of the National Academy of Sciences of the United States of America (2012)
KCNQ2 encephalopathy: Features, mutational hot spots, and ezogabine treatment of 11 patients.
John J. Millichap;Kristen L. Park;Tammy Tsuchida;Bruria Ben-Zeev.
Neurology Genetics (2016)
Cannabidiol as a Potential Treatment for Febrile Infection-Related Epilepsy Syndrome (FIRES) in the Acute and Chronic Phases.
Jacqueline S. Gofshteyn;Angus Wilfong;Orrin Devinsky;Judith Bluvstein.
Journal of Child Neurology (2017)
Identification of Arx transcriptional targets in the developing basal forebrain
Carl T. Fulp;Ginam Cho;Eric D. Marsh;Ilya M. Nasrallah.
Human Molecular Genetics (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: